Zimmerman G A, McIntyre T M, Mehra M, Prescott S M
Nora Eccles Harrison Cardiovascular Research and Training Institute, Salt Lake City, Utah.
J Cell Biol. 1990 Feb;110(2):529-40. doi: 10.1083/jcb.110.2.529.
The binding of neutrophils (polymorphonuclear leukocytes [PMNs]) to endothelial cells (ECs) presents special requirements in the regulation of intercellular adhesion. ECs that are stimulated by certain agonists, including thrombin and cytokines (tumor necrosis factor alpha, interleukin-1), generate molecular signals that induce the adhesion of PMNs (endothelial cell-dependent neutrophil adhesion). Our experiments demonstrate that the mechanism of binding induced by thrombin is distinct from that induced by the cytokines based on the time courses, the requirement for protein synthesis, and differential binding of HL60 promyelocytic leukemia cells to ECs activated by the two classes of agonists. The rapid EC-dependent PMN adhesion (initiated in minutes) that occurs when the ECs are stimulated by thrombin is temporally coupled with the accumulation of platelet-activating factor, a biologically active phosphoglyceride that remains associated with ECs and that activates PMNs by binding to a cell surface receptor. A portion of the newly synthesized platelet-activating factor (PAF) is on the EC surface, as demonstrated by experiments in which the rate of hydrolysis of PAF synthesized by activated ECs was accelerated by extracellular PAF acetylhydrolase. When ECs were treated with exogenous PAF they became adhesive for PMNs; the PMN binding was prevented by incubating the ECs with PAF acetylhydrolase or by treating the PMNs with competitive PAF receptor antagonists. Thus PAF associated with the EC plasma membrane induces PMN binding, an observation supported by experiments in which PAF in model membranes (liposomes) stimulated rapid PMN adhesion to ECs and to cell-free surfaces. In addition, competitive antagonists of the PAF receptor inhibited the binding of PMNs to ECs activated by thrombin and other rapidly acting agonists, but not to ECs activated by tumor necrosis factor alpha, indicating that PAF that is endogenously synthesized by ECs can mediate neutrophil adhesion. These experiments demonstrate a novel mechanism by which a cell-associated phospholipid, PAF, can serve as a signal for an intercellular adhesive event.
中性粒细胞(多形核白细胞[PMN])与内皮细胞(EC)的结合在细胞间黏附调节方面有特殊要求。受某些激动剂刺激的内皮细胞,包括凝血酶和细胞因子(肿瘤坏死因子α、白细胞介素-1),会产生诱导PMN黏附的分子信号(内皮细胞依赖性中性粒细胞黏附)。我们的实验表明,基于时间进程、蛋白质合成需求以及HL60早幼粒细胞白血病细胞与两类激动剂激活的EC的差异结合,凝血酶诱导的结合机制与细胞因子诱导的不同。当EC受到凝血酶刺激时发生的快速内皮细胞依赖性PMN黏附(数分钟内启动)在时间上与血小板活化因子的积累相关,血小板活化因子是一种生物活性磷酸甘油酯,它与EC保持结合并通过与细胞表面受体结合激活PMN。如实验所示,新合成的血小板活化因子(PAF)一部分存在于EC表面,在这些实验中,细胞外PAF乙酰水解酶加速了活化EC合成的PAF的水解速率。当用外源性PAF处理EC时,它们对PMN变得具有黏附性;通过用PAF乙酰水解酶孵育EC或用竞争性PAF受体拮抗剂处理PMN可阻止PMN结合。因此,与EC质膜相关的PAF诱导PMN结合,这一观察结果得到了模型膜(脂质体)中的PAF刺激PMN快速黏附于EC和无细胞表面的实验支持。此外,PAF受体的竞争性拮抗剂抑制了PMN与凝血酶和其他快速作用激动剂激活的EC的结合,但不抑制与肿瘤坏死因子α激活的EC的结合,表明EC内源性合成的PAF可介导中性粒细胞黏附。这些实验证明了一种新机制,即细胞相关磷脂PAF可作为细胞间黏附事件的信号。